Informed by the European Union Experience: What the United States Can Anticipate and Learn from the European Union's Regulatory Approach to Biosimilars.Published in:Seton Hall Law Review, 2011, v. 41, n. 2, p. 559By:Gitter, Donna M.Publication type:Article
Demystifying Patent Holdup.Published in:Washington & Lee Law Review, 2019, v. 76, n. 4, p. 1501By:Cotter, Thomas F.;Hovenkamp, Erik;Siebrasse, NormanPublication type:Article
From the Ivory Tower to Your Household: How One Beverage Helped Create a Far-Reaching Legal Industry.Published in:Advocate (05154987), 2022, v. 65, n. 9, p. 14By:Tamsen, Jeremy K.Publication type:Article
BRIDGING THE (LIABILITY) GAP: THE SHIFT TOWARD § 271(b) INDUCEMENT IN AKAMAI REPRESENTS A PARTIAL SOLUTION TO DIVIDED INFRINGEMENT.Published in:Boston College Law Review, 2013, v. 54, n. 5, p. 2127By:JACKSON, BRETT M.Publication type:Article
PATENT OPPOSITIONS IN AUSTRALIA: THE FACTS.Published in:University of New South Wales Law Journal, 2011, v. 34, n. 1, p. 93By:WEATHERALL, KIMBERLEE;ROTSTEIN, FIONA;DENT, CHRIS;CHRISTIE, ANDREWPublication type:Article